Quarterly report pursuant to Section 13 or 15(d)

Clinical Trial and Sponsored Research Agreements (Tables)

v3.22.2
Clinical Trial and Sponsored Research Agreements (Tables)
6 Months Ended
Jun. 30, 2022
Sponsored Research and Clinical Trial Agreements [Member]  
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]  
Schedule of Clinical Trial and Sponsored Research Agreements

For the three and six months ended June 30, 2022 and 2021, the Company recorded the following expense in research and development for sponsored research and clinical trial agreements in the Unaudited Statements of Operations pursuant to the terms of this agreement:

For the three months ended June 30, 

For the six months ended June 30, 

($ in thousands)

    

2022

    

2021

    

2022

    

2021

City of Hope National Medical Center

$

$

$

$

CD123

52

21

103

226

IL13Rα2

234

279

462

793

CS1

50

197

100

372

HER2

271

31

542

154

PSCA

28

(4)

50

46

Fred Hutchinson Cancer Research Center - CD20

358

327

846

998

St. Jude Children's Research Hospital - XSCID

94

176

218

280

LUMC - RAG1 SCID

138

265

Mayo Clinic

231

233

462

233

Total

$

1,456

$

1,260

$

3,048

$

3,102